22-41146749-A-G
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001429.4(EP300):āc.2064A>Gā(p.Leu688=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00358 in 1,614,102 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. L688L) has been classified as Likely benign.
Frequency
Consequence
NM_001429.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EP300 | NM_001429.4 | c.2064A>G | p.Leu688= | synonymous_variant | 11/31 | ENST00000263253.9 | |
EP300 | NM_001362843.2 | c.2054-1088A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EP300 | ENST00000263253.9 | c.2064A>G | p.Leu688= | synonymous_variant | 11/31 | 1 | NM_001429.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00277 AC: 422AN: 152228Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00307 AC: 772AN: 251406Hom.: 2 AF XY: 0.00310 AC XY: 421AN XY: 135868
GnomAD4 exome AF: 0.00367 AC: 5358AN: 1461756Hom.: 13 Cov.: 30 AF XY: 0.00378 AC XY: 2746AN XY: 727172
GnomAD4 genome AF: 0.00277 AC: 422AN: 152346Hom.: 2 Cov.: 32 AF XY: 0.00248 AC XY: 185AN XY: 74502
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 14, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 19, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 14, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | EP300: BP4, BP7, BS1, BS2 - |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 30, 2024 | - - |
EP300-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 29, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at